Open Access

Erratum to: Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis

  • Janus Christian Jakobsen1, 2Email author,
  • Kiran Kumar Katakam1,
  • Anne Schou1,
  • Signe Gade Hellmuth1,
  • Sandra Elkjær Stallknecht1,
  • Katja Leth-Møller1,
  • Maria Iversen1,
  • Marianne Bjørnø Banke1,
  • Iggiannguaq Juhl Petersen1,
  • Sarah Louise Klingenberg1,
  • Jesper Krogh3,
  • Sebastian Elgaard Ebert1,
  • Anne Timm1,
  • Jane Lindschou1 and
  • Christian Gluud1
BMC PsychiatryBMC series – open, inclusive and trusted201717:162

DOI: 10.1186/s12888-017-1311-5

Received: 23 March 2017

Accepted: 12 April 2017

Published: 3 May 2017

The original article was published in BMC Psychiatry 2017 17:58

Erratum

After the publication of this paper the authors noticed a few errors in the text. There are outlines below:
  1. 1.

    Results section, under Hamilton depression rating scale (HDRS): In the sentence ‘Nineteen trials reported only mean HDRS change scores or presented a graph showing the mean change HDRS scores, but did not report the SD’ Eighteen should replace Nineteen

     
  2. 2.

    Results section, under Hamilton depression rating scale (HDRS):In the sentence ‘Random-effects meta-analysis of the results of all 92 trials showed that SSRIs versus placebo significantly reduced the HDRS score (mean difference −2.25 points; 95% CI −2.69 to −1.83; P<0.00001)’ 91 should replace 92

     
  3. 3.

    Results section, under Other subgroup analyses: In the sentence ‘Meta-analysis of the results of the 26 trials with a mean baseline HDRS score >23 points showed a mean difference of −2.69 HDRS points; 95% CI −3.59 to −1.78; P<0.00001.’ 25 should replace 26

     
  4. 4.

    Table 2 [Summary of serious adverse events in the included trials] ‘Nemroff et al., 2005’ should read ‘Nemeroff et al., 2007’ and in the same line ‘Fluxetine’ should read ‘Fluoxetine

     

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812 Rigshospitalet, Copenhagen University Hospital
(2)
Department of Cardiology, Holbæk Hospital
(3)
Mental Health Centre Copenhagen, Faculty of Health Sciences, University of Copenhagen

Reference

  1. Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-Møller K, Iversen M, Banke MB, Petersen IJ, Klingenberg SL, Krogh J, Ebert SE, Timm A, Lindschou J, Gluud C. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder, A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry. 2017;17:58. doi:10.1186/s12888-016-1173-2.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement